(18) demonstrated in a retrospective analysis of 3,441 early-stage breast cancers that subtype as approximated by ER, PR, and HER-2 was predictive of nodal involvement, independent of grade and tumor size. This evidence concerns the gene ERBB2 and breast carcinoma.